![Fresenius Kabi Signs an Agreement with Medec to Commercialize IDACIO (adalimumab- biosimilar) in Germany Fresenius Kabi Signs an Agreement with Medec to Commercialize IDACIO (adalimumab- biosimilar) in Germany](https://pharmashots.com/public/images/20211116004752_ogImage_38.jpg)
Fresenius Kabi Signs an Agreement with Medec to Commercialize IDACIO (adalimumab- biosimilar) in Germany
![Fresenius Kabi Launches Idacio (biosimilar- adalimumab) for Multiple Chronic Inflammatory Conditions in Canada Fresenius Kabi Launches Idacio (biosimilar- adalimumab) for Multiple Chronic Inflammatory Conditions in Canada](https://pharmashots.com/public/images/20211116013707_original_7.webp)
Fresenius Kabi Launches Idacio (biosimilar- adalimumab) for Multiple Chronic Inflammatory Conditions in Canada
![Fresenius Kabi Launches Idacio (biosimilar, adalimumab) in the US for the Treatment of Chronic Autoimmune Diseases Fresenius Kabi Launches Idacio (biosimilar, adalimumab) in the US for the Treatment of Chronic Autoimmune Diseases](https://www.pharmashots.com/public/images/20220505184409_ogImage_42.jpg)
Fresenius Kabi Launches Idacio (biosimilar, adalimumab) in the US for the Treatment of Chronic Autoimmune Diseases
![Fresenius Kabi's Idacio (adalimumab- biosimilar) Receives EU's Marketing Approval in Rheumatology- Gastroenterology and Dermatology Fresenius Kabi's Idacio (adalimumab- biosimilar) Receives EU's Marketing Approval in Rheumatology- Gastroenterology and Dermatology](https://pharmashots.com/public/images/20211115223529_original_43.webp)
Fresenius Kabi's Idacio (adalimumab- biosimilar) Receives EU's Marketing Approval in Rheumatology- Gastroenterology and Dermatology
![Fresenius Kabi Canada Launches IDACIO® (adalimumab injection) a Biosimilar to HUMIRA® (adalimumab) for the Treatment of Multiple Chronic Inflammatory Conditions Fresenius Kabi Canada Launches IDACIO® (adalimumab injection) a Biosimilar to HUMIRA® (adalimumab) for the Treatment of Multiple Chronic Inflammatory Conditions](https://mma.prnewswire.com/media/1440732/Fresenius_Kabi_Fresenius_Kabi_Canada_Launches_IDACIO___adalimuma.jpg?p=twitter)
Fresenius Kabi Canada Launches IDACIO® (adalimumab injection) a Biosimilar to HUMIRA® (adalimumab) for the Treatment of Multiple Chronic Inflammatory Conditions
![Fresenius Kabi Launches Idacio (biosimilar, adalimumab) in the US for the Treatment of Chronic Autoimmune Diseases Fresenius Kabi Launches Idacio (biosimilar, adalimumab) in the US for the Treatment of Chronic Autoimmune Diseases](https://www.pharmashots.com/public/images/20211116004748_original_12.webp)
Fresenius Kabi Launches Idacio (biosimilar, adalimumab) in the US for the Treatment of Chronic Autoimmune Diseases
![Fresenius Kabi launches its citrate-free biosimilar Idacio® (adalimumab-aacf) in the United States - Fresenius Kabi Global Fresenius Kabi launches its citrate-free biosimilar Idacio® (adalimumab-aacf) in the United States - Fresenius Kabi Global](https://www.fresenius-kabi.com/images/launch-of-citrate-free-biosimilar-Idacio.jpg)